Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-001092

Chief Operating Officer sold 3,584 shares at $1.69 ($6,071)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2023-01-04 Sale −3,584 $1.69 $6,071 5,781 D
Open-market sales · 3,584 sh · avg $1.69 · $6,071
Loading xslF345X03/tm231655-4_4seq1.xml…